![Unlock the Power of Data Review and Collaboration: Maximizing Trial Success - PerkinElmer Informatics Unlock the Power of Data Review and Collaboration: Maximizing Trial Success - PerkinElmer Informatics](https://perkinelmerinformatics.com/sites/default/files/2023-02/LinkedIn.jpg)
Unlock the Power of Data Review and Collaboration: Maximizing Trial Success - PerkinElmer Informatics
![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/1d41ebf5-9657-435f-9dff-165db3d18406/gr2_lrg.jpg)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
![CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - ScienceDirect CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1071916410010493-gr2.jpg)
CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - ScienceDirect
![BostonSci Cardiology on Twitter: "With over 150,000 NVAF patients implanted with WATCHMAN #LAAC Solution devices, CHAMPION-AF evaluates the WATCHMAN FLX™ device as a safe and effective first-line option vs. NOAC for stroke BostonSci Cardiology on Twitter: "With over 150,000 NVAF patients implanted with WATCHMAN #LAAC Solution devices, CHAMPION-AF evaluates the WATCHMAN FLX™ device as a safe and effective first-line option vs. NOAC for stroke](https://pbs.twimg.com/media/E_w4xBzVcAk6WtO.jpg)
BostonSci Cardiology on Twitter: "With over 150,000 NVAF patients implanted with WATCHMAN #LAAC Solution devices, CHAMPION-AF evaluates the WATCHMAN FLX™ device as a safe and effective first-line option vs. NOAC for stroke
![Alexion Announces Planned Initiation of Pivotal Phase 3 Study of ULTOMIRIS® (ravulizumab) in ALS - Clinical Trial Recruitment Alexion Announces Planned Initiation of Pivotal Phase 3 Study of ULTOMIRIS® (ravulizumab) in ALS - Clinical Trial Recruitment](https://mms.businesswire.com/media/20200114005254/en/767166/4/480_Alexion_CHAMPION-ALS_Trial_visual_10Jan2020.jpg)
Alexion Announces Planned Initiation of Pivotal Phase 3 Study of ULTOMIRIS® (ravulizumab) in ALS - Clinical Trial Recruitment
![Lessons learned about the effective operationalization of champions as an implementation strategy: results from a qualitative process evaluation of a pragmatic trial | Center for Primary Care Research & Innovation Lessons learned about the effective operationalization of champions as an implementation strategy: results from a qualitative process evaluation of a pragmatic trial | Center for Primary Care Research & Innovation](https://bridgetoinnovation.org/wp-content/uploads/2021/03/Implementation-Champions-infographic-pdf.jpg)
Lessons learned about the effective operationalization of champions as an implementation strategy: results from a qualitative process evaluation of a pragmatic trial | Center for Primary Care Research & Innovation
![CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - ScienceDirect CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1071916410010493-gr1.jpg)
CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System - ScienceDirect
![CHAMPION-AF trial available for A-fib patients in Louisville, Southern Indiana - Norton Healthcare Provider Louisville, Ky. CHAMPION-AF trial available for A-fib patients in Louisville, Southern Indiana - Norton Healthcare Provider Louisville, Ky.](https://nortonhealthcareprovider.com/wp-content/uploads/Champion_AF_watchman_flx_trial-c.jpg)
CHAMPION-AF trial available for A-fib patients in Louisville, Southern Indiana - Norton Healthcare Provider Louisville, Ky.
![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2062646893/2065058613/gr1.gif)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
![BostonSci Cardiology on Twitter: "The CHAMPION-AF clinical trial aims to expand a first-line #LAAC option to lower risk patients by evaluating LAAC in patients with CHA₂DS₂-VASc scores of ≥ 2 for men BostonSci Cardiology on Twitter: "The CHAMPION-AF clinical trial aims to expand a first-line #LAAC option to lower risk patients by evaluating LAAC in patients with CHA₂DS₂-VASc scores of ≥ 2 for men](https://pbs.twimg.com/media/FI0rHQpXEAIi1Vi.jpg)
BostonSci Cardiology on Twitter: "The CHAMPION-AF clinical trial aims to expand a first-line #LAAC option to lower risk patients by evaluating LAAC in patients with CHA₂DS₂-VASc scores of ≥ 2 for men
![CLINICAL TRIALS - Spotlight on Quality in Study Startup: Automated Workflows Encourage Upfront Planning & Downstream Improvements in the eTMF CLINICAL TRIALS - Spotlight on Quality in Study Startup: Automated Workflows Encourage Upfront Planning & Downstream Improvements in the eTMF](https://drug-dev.com/wp-content/uploads/2019/01/T1-1.jpg)
CLINICAL TRIALS - Spotlight on Quality in Study Startup: Automated Workflows Encourage Upfront Planning & Downstream Improvements in the eTMF
CHAMPION Clinical Trial: Substantial reduction in 30-day readmissions in Medicare-eligible patients - Background and Rationale for Implantable Hemodynamic Monitoring - Hemodynamic Monitoring for Heart Failure Patients
![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/79530aaf-6278-4927-b5a0-6700e1a422b1/gr3_lrg.jpg)